FDA Expands Repotrectinib Label to All NTRK Gene Fusion+ Solid TumorsJune 14, 2024Patient & Survivor CareLung CancerPractice ManagementCNS/Brain CancerBreast CancerGastrointestinal CancerGenitourinary Cancer
Ovarian Cancer Risk Doubled by Estrogen-Only HRTJune 12, 2024Gynecologic CancerPatient & Survivor CarePreventive CareBreast Cancer
Are Children Born Through ART at Higher Risk for Cancer?June 10, 2024Preventive CarePediatricsBreast CancerCNS/Brain CancerDLBCLFollicular LymphomaGastrointestinal Cancer
About 20% of Breast Cancer Survivors Gain Excess WeightJune 10, 2024Breast CancerPatient & Survivor Care
T-DXd Moves Toward First Line for HER2-Low Metastatic BCJune 10, 2024Metastatic Breast CancerBreast CancerPatient & Survivor CareASCO Breast Cancer
Anti-Müllerian Hormone Predicts Chemo Benefits in BCJune 6, 2024Breast CancerPatient & Survivor CareASCO Breast Cancer
Should ER-Low Breast Cancer Patients Be Offered Endocrine Therapy?June 5, 2024Breast CancerPatient & Survivor CareASCO Breast Cancer
Abemaciclib Plus Fulvestrant Improves Survival in Advanced Breast CancerJune 3, 2024Breast CancerPatient & Survivor CareASCO Breast Cancer
Carefully Designing De-escalation Trials in Breast CancerMay 31, 2024Breast CancerPatient & Survivor CarePractice Management
ADCs for Breast Cancer: Clear Benefits, Manageable RisksMay 31, 2024Metastatic Breast CancerBreast CancerPatient & Survivor Care
The ASCO Annual Meeting Starts This WeekMay 30, 2024Mixed TopicsPractice ManagementSarcoma & GISTRenal Cell CarcinomaBreast CancerCNS/Brain CancerDLBCL
Exercise Improves Sexual Health in Women With Metastatic Breast CancerMay 30, 2024Metastatic Breast CancerBreast Cancer
ASTRO Releases New EBRT Guideline for Symptomatic Bone MetsMay 29, 2024Patient & Survivor CareBreast CancerCNS/Brain CancerDLBCLFollicular LymphomaGastrointestinal CancerGenitourinary Cancer
ASCO Provides Guidance on CDK4/6 Inhibitors for Early Breast CancerMay 29, 2024Breast CancerPatient & Survivor Care
